Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 08, 2022

SELL
$40.23 - $47.74 $7,643 - $9,070
-190 Reduced 7.97%
2,195 $96,000
Q4 2021

Jan 18, 2022

SELL
$38.88 - $45.31 $59,214 - $69,007
-1,523 Reduced 38.97%
2,385 $105,000
Q3 2021

Oct 14, 2021

SELL
$38.79 - $43.16 $22,498 - $25,032
-580 Reduced 12.92%
3,908 $149,000
Q2 2021

Jul 15, 2021

SELL
$36.52 - $41.46 $157,949 - $179,314
-4,325 Reduced 49.08%
4,488 $179,000
Q1 2021

Apr 13, 2021

SELL
$34.27 - $40.01 $13,365 - $15,603
-390 Reduced 4.24%
8,813 $315,000
Q4 2020

Jan 13, 2021

SELL
$34.07 - $39.94 $3,407 - $3,994
-100 Reduced 1.07%
9,203 $339,000
Q3 2020

Oct 14, 2020

SELL
$38.11 - $42.99 $8,193 - $9,242
-215 Reduced 2.26%
9,303 $350,000
Q2 2020

Jul 07, 2020

BUY
$37.87 - $43.58 $127,432 - $146,646
3,365 Added 54.69%
9,518 $388,000
Q1 2020

Apr 14, 2020

BUY
$32.47 - $48.83 $73,869 - $111,088
2,275 Added 58.66%
6,153 $233,000
Q4 2019

Jan 16, 2020

SELL
$42.0 - $48.25 $12,600 - $14,475
-300 Reduced 7.18%
3,878 $182,000
Q3 2019

Oct 22, 2019

BUY
$40.46 - $43.52 $5,057 - $5,440
125 Added 3.08%
4,178 $178,000
Q1 2019

Apr 12, 2019

SELL
$38.57 - $42.69 $3,085 - $3,415
-80 Reduced 1.94%
4,053 $169,000
Q4 2018

Jan 16, 2019

BUY
$37.8 - $42.69 $20,223 - $22,839
535 Added 14.87%
4,133 $158,000
Q3 2018

Oct 16, 2018

BUY
$39.75 - $42.69 $21,624 - $23,223
544 Added 17.81%
3,598 $145,000
Q2 2018

Jul 12, 2018

BUY
$39.61 - $42.76 $36,599 - $39,510
924 Added 43.38%
3,054 $123,000
Q1 2018

Apr 10, 2018

BUY
$36.18 - $40.15 $32,923 - $36,536
910 Added 74.59%
2,130 $83,000
Q4 2017

Jan 16, 2018

SELL
$35.34 - $41.9 $65,379 - $77,515
-1,850 Reduced 60.26%
1,220 $43,000
Q3 2017

Oct 20, 2017

BUY
$39.44 - $41.55 $121,080 - $127,558
3,070
3,070 $125,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Norway Savings Bank Portfolio

Follow Norway Savings Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norway Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norway Savings Bank with notifications on news.